Conference Coverage

Prostate cancer risk before age 55 higher for black men

 

Key clinical point: Black race appears to be a key risk factor for prostate cancer in younger men.

Major finding: Black men younger than age 55 years undergoing prostate biopsies were 5.6 times more likely than other men to have a positive biopsy result.

Study details: Retrospective analysis of 564 men.

Disclosures: The study received funding from the National Institutes of Health and the U.S. Department of Veterans Affairs. Dr. Nettey reported having no financial disclosures.

Source: Nettey OS et al. AUA Annual Meeting. Abstract MP 21-17.


 

REPORTING FROM THE AUA ANNUAL MEETING

– Among men aged younger than 55 years undergoing prostate biopsies, black men were more likely to have a diagnosis of prostate cancer, according to a new study that drew subjects aged 40-54 years from three public and two private hospitals in the Chicago area.

Black race, rather than socioeconomic or clinical factors, appeared to be the strongest nonmodifiable predictor of prostate cancer risk in that age group, the researchers concluded, based on multivariate analyses that examined the association between prostate cancer risk and clinical setting, race, genetically determined West African ancestry, and clinical and socioeconomic risk factors.

Dr. Oluwarotimi S. Nettey of Northwestern University, Chicago

Dr. Oluwarotimi S. Nettey

The study included 564 men older than age 40 years undergoing initial prostate biopsy for abnormal prostate-specific antigen (PSA) levels or digital rectal examination results from three publicly funded and two private hospitals during 2009-2014. When limiting the analysis to men younger than age 55 years, black race (odds ratio,13.49; P = .01) and family history (OR, 5.12; P = .03) were independently associated with overall prostate cancer diagnosis.

The results suggest that screening practices should be altered, said study investigator Oluwarotimi S. Nettey, MD, of Northwestern University, Chicago. “You might want to think about screening black men who are younger than 55.”

“In the prebiopsy space, most studies have looked at race, age, PSA [level], and prostate volume, and they’ve said that the reason we see that black men have disparate prostate cancer risk on diagnosis is probably because of access to care issues, so that’s been the confounder. We tried to control for this by looking at socioeconomic status through income, marriage, and education, as well as hospital setting,” said Dr. Nettey, who presented the study at a poster session at the annual meeting of the American Urological Association.

Previous studies have examined populations and then conducted a secondary analysis on outcomes in black men. The current study has greater power and is more convincing because outcomes in black men was the primary outcome of the study, according to Robert L. Waterhouse Jr., MD, who is the public policy liaison for the R. Frank Jones Urological Society of the National Medical Association. Dr. Waterhouse, a urologist in Charlotte, N.C., attended the poster session and was not involved in the research.

“This study helps to provide some evidence that black heritage is indeed a significant risk factor in men who develop prostate cancer at an earlier age, and efforts at identifying prostate cancer at an earlier age [should consider] black race as a high-risk group,” said Dr. Waterhouse.

Next Article:

   Comments ()